Chronic Workplace Stress Is a Disease Risk

Occupational Health Cardiovascular Risk Organisational Health

Chronic Workplace Stress is a Disease Risk

What Your Organisation’s Wellness Programme Is Missing

What almost never happens inside organisations responding to rising stress is someone asking whether their workforce is accumulating measurable, physiological damage from the way the organisation operates. Not burnout in the colloquial sense. Actual, documentable cardiovascular, metabolic, and immune system damage that compounds year over year, often invisibly, until it announces itself as a diagnosis.

Let me describe a pattern I have seen repeated across dozens of Indian organisations over the past twenty years. An HR team notices that engagement scores are declining, attrition is rising, or employee satisfaction surveys are flagging stress as a top concern. The response is predictable. A wellness webinar gets scheduled. A meditation app subscription is offered. Maybe a yoga session is added to the quarterly calendar. The engagement survey gets re-run six months later. If the numbers improve slightly, the programme is declared a success.

What almost never happens is someone asking whether the people inside the organisation are accumulating measurable, physiological damage from the way the organisation operates. This is not a theoretical concern. It is happening right now, at scale, inside Indian corporate workforces. And the data on it is considerably more specific and more alarming than most HR leaders have been told.

The body’s primary stress response system, the hypothalamic-pituitary-adrenal (HPA) axis, works through a well-characterised chain. The hypothalamus releases corticotropin-releasing hormone. The pituitary releases adrenocorticotropic hormone. The adrenal glands release cortisol. In a healthy system, cortisol itself feeds back to the hypothalamus and pituitary in a negative feedback loop, shutting down further production once the immediate demand has passed. This is a self-limiting system. It was built for short, resolvable physical threats.

The problem begins when stress becomes chronic rather than episodic. Continuous, low-level activation, sustained by an always-on work culture, unresolved interpersonal dynamics, or sustained financial pressure, can keep the HPA axis effectively stuck in the “on” position. The negative feedback loop that is supposed to shut it down stops working properly. Cortisol stays elevated. And the consequences ripple across multiple organ systems simultaneously. Sustained cortisol elevation raises blood pressure, increases appetite and abdominal fat accumulation, suppresses immune function, and disrupts sleep architecture. These are not disconnected side effects. They are a single, interconnected biological cascade.

Research using hair cortisol concentration, a biomarker reflecting cumulative cortisol exposure over months rather than a single snapshot, found that elevated long-term cortisol predicted increases in both immune and cardiovascular allostatic load at the same time point, and a separate increase in metabolic allostatic load measured four years later. The level of work-related stress measurably influenced this relationship.

That four-year lag is critical. An organisation can look at its workforce, see no obvious metabolic problems today, and wrongly conclude the risk is not accumulating. By the time the damage becomes clinically visible, years of exposure have already been banked. The cortisol rhythm makes this visible. In a healthy system, cortisol follows a sharp rise shortly after waking, then declines steadily across the day. Research comparing chronically stressed individuals against controls found that cortisol profiles in the stressed group showed a flattened diurnal slope with elevated evening cortisol. This flattened pattern has been consistently observed across populations experiencing chronic work stress. Elevated cortisol and the flattened diurnal slope correlated strongly and inversely with simultaneous elevations in interleukin-6, tumour necrosis factor-alpha, and C-reactive protein, all established inflammatory markers implicated in cardiovascular disease, diabetes, and depression. The endocrine consequences and the immune consequences of chronic stress are not separate problems. They are the same problem, viewed through different lenses.

Section 01

The Cardiovascular Risk Is Not Speculative. It Is Quantified.

Two dominant occupational health models have been validated against hard cardiovascular endpoints across large prospective studies.

01

The Demand-Control Model (Karasek)

Robert Karasek’s demand-control model identifies the highest cardiovascular risk in jobs combining high psychological demand with low individual control. The model has been validated against actual cardiovascular outcomes, not self-reported wellbeing, across large prospective cohort studies. A meta-analysis of these studies found that employees with high job strain carried a pooled hazard ratio of 1.23 for coronary heart disease compared with employees without job strain.

02

The Effort-Reward Imbalance Model (Siegrist)

Johannes Siegrist’s effort-reward imbalance model identifies cardiovascular risk where sustained high effort meets inadequate reward, whether financial, status-based, or security-related. A separate multicohort study spanning over 90,000 individuals found effort-reward imbalance independently associated with incident coronary heart disease at a hazard ratio of 1.16. One study examining the combined effect of both patterns found a relative risk for cardiovascular disease mortality of 2.20 for high job strain alone and 2.36 for high effort-reward imbalance alone, each compared against low-strain employees.

These are not dramatic, headline-grabbing multiples. They are the kind of steady, compounding risk increases that, applied across a workforce of hundreds or thousands over a decade, produce a genuinely significant excess burden of preventable disease.
Section 02

Long Working Hours Carry an Independent, Separately Quantified Risk

A separate and more recent body of evidence has isolated working hours themselves as an independent cardiovascular risk factor, distinct from job strain or effort-reward imbalance. The first joint global analysis by the World Health Organization and the International Labour Organization, drawing on systematic reviews and meta-analyses of dozens of underlying studies, found sufficient evidence that working 55 or more hours per week is associated with a 35 percent higher risk of stroke and a 17 percent higher risk of dying from ischaemic heart disease, compared with a standard 35 to 40 hour week.

This is now formally the occupational risk factor carrying the largest documented global burden of work-related disease, responsible for an estimated 745,000 deaths from stroke and ischaemic heart disease combined in 2016 alone. That number represents a 29 percent increase from the year 2000. The trend is moving in the wrong direction.
Section 03

India Sits at the Centre of This, Not at the Periphery

The same WHO and ILO analysis found that the South-East Asia region (the WHO’s regional classification that includes India) carried the highest prevalence globally of workers exposed to 55 or more hours per week, at 11.7 percent of the working population. Higher than every other world region tracked. South Asia has been identified as having the longest average working hours in the world, at 49 hours per week.

The Cigna 360 Well-Being Survey found that 89 percent of Indian respondents reported feeling stressed, compared with a global average of 84 percent. Gallup data identified South Asian countries, including India, as experiencing daily anger and stress at notably higher rates than the United States, Europe, Canada, and Sub-Saharan Africa.

But the data that should concern a CHRO most is not the survey data. It is the biomarker data.

Peer-reviewed research conducted specifically among corporate IT employees in South India found that 29.87 percent of the studied population already met the criteria for metabolic syndrome. Those affected showed significantly higher levels of oxidative stress and inflammatory biomarkers. And perceived stress was significantly higher among senior, managerial-level employees specifically, meaning the leadership layer of an organisation, the people making its most consequential decisions, may be carrying a disproportionate share of this measurable physiological burden.

This is not imported Western research applied speculatively to India. This is Indian data, from Indian corporate employees, showing measurable biological damage that maps directly onto the mechanisms described above.

Section 04

Women Face a Different, and in Some Respects More Dangerous, Pathway

This is one of the more counterintuitive findings in the current literature, and it has direct implications for programme design. Research has found that stress-induced cortisol release tends to be greater in men than in women on average. But this does not mean men carry the greater cardiovascular risk from psychological stress.

A comprehensive review found that psychological stress significantly predicts coronary events in women, while this predictive relationship is considerably less evident in men. Women’s cardiovascular systems appear more sensitive to the downstream effects of a given level of psychological stress, even when the absolute hormonal response is smaller.

Women also exhibit higher platelet reactivity to stress compared with men. Women with existing coronary artery disease are more susceptible to mental stress-induced myocardial ischaemia. And women are specifically more vulnerable to certain stress-triggered cardiac conditions, including Takotsubo syndrome, a coronary disorder induced by profound psychological stress. A workplace stress and cardiovascular risk model calibrated purely on absolute cortisol output would systematically underestimate the cardiovascular risk carried by women.

Post-menopausal women carry a further elevated risk. Postmenopausal women have been shown to exhibit heightened haemodynamic responses to stress, including elevated blood pressure and heart rate reactivity, attributable in part to the more atherogenic lipid profile and increased visceral fat accumulation accompanying the menopausal transition. The same chronic workplace stress exposure may carry a measurably different risk for a senior female executive in her fifties compared with a younger colleague. A uniform, age-blind approach would miss this entirely.

Section 05

What Actually Works, and What Does Not

The evidence separates clearly between interventions that address the actual mechanism producing cardiovascular risk, and interventions that are prevalent despite weak or contradicted evidence.

Highest Impact, Strongest Evidence

Address job demand, control, and reward structure as the primary intervention target. The strongest, most consistently replicated cardiovascular risk findings are tied to these structural characteristics, not to individual coping skills. This requires genuine organisational design change: restructuring decision latitude, addressing reward fairness, and reducing the demand patterns that keep the HPA axis permanently activated.

Train managers directly. A 2024 meta-analysis found that manager training in mental health literacy specifically reduces team-level burnout. Indian-specific research independently identifies manager behaviour as a key driver of team stress. This is currently the single most evidence-supported intervention point available.

Treat long working hours as an independent risk factor requiring direct organisational attention. Given the WHO/ILO evidence and India’s position as the highest-prevalence region globally for 55-plus hour weeks, this requires explicit policy attention to hours, not just workload.

Evidence-Based Priority

What Doesn’t Work Despite Common Practice

Individual-level wellness perks as a substitute for structural change. The strongest available evidence ties cardiovascular risk to job demand, control, and reward structure. A major review explicitly noted insufficient high-quality evidence to support workplace stress reduction programmes as reliable primary cardiovascular disease prevention on their own. A meditation app does not change the job characteristics producing the risk.

Assuming the absence of symptoms means the absence of risk. The lag between chronic cortisol elevation and measurable metabolic allostatic load can extend to four years or more. An apparently healthy workforce may be carrying a significant, invisible, accumulating burden.

Treating this as a younger employee’s problem. Allostatic load is cumulative. The WHO/ILO data found cardiovascular burden concentrated among middle-aged and older workers. Senior, longer-tenured employees are likely carrying the greatest accumulated physiological risk.

Common but Ineffective

Three additional interventions have strong supplementary evidence:

Introduce biomarker-based screening for inflammatory and metabolic risk among senior, high-strain employees. Given the four-year lag between cortisol elevation and measurable metabolic consequences, and the Indian-specific findings of elevated oxidative stress among senior IT employees, biomarker screening offers a meaningfully earlier warning signal than waiting for self-reported decline or a clinical diagnosis.
Calibrate cardiovascular risk assessment by sex. Applying a uniform model based on hormonal output will underestimate risk in women. This is a documented, repeatedly observed pattern with direct implications for how screening and intervention programmes should be designed.
Build structurally protected recovery periods into work design. The core problem is a stress response system that never gets the signal to switch off. Recovery periods that exist on paper but are practically undermined by ongoing workload expectations do not interrupt that sustained activation.
Chronic workplace stress is not an engagement metric. It is an occupational health exposure with quantified disease consequences. An organisation that continues treating this purely as a voluntary wellness initiative is not being cautious. It is being negligent about a recognised, quantified, and in the Indian context unusually severe risk sitting inside its own workforce.

Organisational Health and Performance Programme

At Deep-Health, we treat chronic stress as what the evidence shows it to be: a sustained physiological exposure requiring structural intervention, not a wellness perk.

We do not treat chronic stress as a soft HR concern. We address it through biomarker awareness, organisational design analysis, and structural interventions that target the demand, control, and reward structures that the evidence identifies as the actual drivers of cardiovascular, metabolic, and immune risk.

Explore Organisational Programmes

Research References

Robert Karasek – Sociologist and researcher; developer of the demand-control model of occupational stress. Referenced for the meta-analysis finding high job strain carries a pooled hazard ratio of 1.23 for coronary heart disease.

Johannes Siegrist – Medical sociologist; developer of the effort-reward imbalance model. Referenced for the multicohort study (90,000+ individuals) finding effort-reward imbalance independently associated with incident coronary heart disease at a hazard ratio of 1.16.

World Health Organization and International Labour Organization (2021) – Joint global analysis on the health effects of working 55 or more hours per week. Referenced for the 35 percent elevated stroke risk, 17 percent elevated ischaemic heart disease mortality risk, and 745,000 deaths estimate for 2016.

Cigna 360 Well-Being Survey – Industry research cited for the finding that 89 percent of Indian respondents reported feeling stressed, compared with a global average of 84 percent.

Gallup – Research organisation. Referenced for data identifying South Asian countries as experiencing higher daily anger and stress rates than the United States, Europe, Canada, and Sub-Saharan Africa.

Hair cortisol concentration research – Biomarker methodology reflecting cumulative cortisol exposure over months. Referenced for the finding that elevated long-term cortisol predicted metabolic allostatic load measured four years later, with work-related stress measurably influencing this relationship.

Disclaimer

The information presented in this article is intended for HR professionals, CHROs, and organisational leaders evaluating occupational health and workforce performance strategies. It draws on published research in occupational medicine, cardiovascular epidemiology, and psychoneuroendocrinology. References to specific studies, models, and surveys are cited for transparency; this article does not constitute a systematic review, clinical publication, or medical advice. Hazard ratios and risk estimates cited are drawn from prospective cohort studies and meta-analyses and reflect population-level associations, not individual predictions. Any decision to implement workforce health screening, biomarker testing, or clinical intervention programmes should involve qualified healthcare professionals and comply with applicable Indian regulatory requirements. Deep-Health does not endorse specific screening or treatment protocols without prior organisational and individual assessment. This content reflects the author’s analysis based on clinical literature and professional experience.

Sanjay Dev

Sanjay Dev

Founder of Deep-Health. 20-plus years working with founders, executives, athletes, and organisations at the intersection of neuroscience, physiology, and behavioural biochemistry.